8 HR Arthritis Pain
NDC 75907-430, ACETAMINOPHEN, tablet, extended release, from Dr. Reddy's Laboratories Inc..
- Product NDC
- 75907-430
- Status
- Listed
- Labeler
- Dr. Reddy's Laboratories Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA211544
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/75907-430 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETAMINOPHEN650 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 75907-430-01 | 75907043001 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (75907-430-01) |
| 75907-430-40 | 75907043040 | 400 TABLET, EXTENDED RELEASE in 1 BOTTLE (75907-430-40) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 75907-430 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/75907-430 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 75907-430. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.